# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Primary progressive aphasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 189 results.
Determining the Influence of Atrophy on Efficacy of tDCS in Treating Primary Progressive Aphasia
Status: Recruiting
Last Changed: Jun 24, 2020
First Received: Mar 25, 2019
Disease(s): Primary Progressive Aphasia
Intervention(s): High-definition active tDCS (HD-tDCS) + "Repeat After Me" (RAM) Treatment, Sham + "Repeat After Me" (RAM) Treatment
Locations: Johns Hopkins Hospital, Baltimore, Maryland, United States
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms
Status: Enrolling by invitation
Last Changed: Aug 28, 2020
First Received: Jan 16, 2019
Disease(s): Primary Progressive Aphasia
Intervention(s): HD-tDCS, Sham
Locations: The Medical College of Wisconsin, Milwaukee, Wisconsin, United States
tDCS Intervention in Primary Progressive Aphasia
Status: Recruiting
Last Changed: Apr 09, 2020
First Received: Nov 17, 2015
Disease(s): Primary Progressive Aphasia, MCI, FTD
Intervention(s): Active HD-tDCS plus Speech-Language Therapy, Sham plus Speech-Language Therapy
Locations: Johns Hopkins Hospital, Baltimore, Maryland, United States
Baseline Severity and tDCS in PPA
Status: Completed
Last Changed: Jun 25, 2020
First Received: Oct 10, 2016
Disease(s): Primary Progressive Aphasia
Intervention(s): transcranial direct current stimulation
Locations: University of Pennsylvania, Philadelphia, Pennsylvania, United States
rTMS for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial
Status: Withdrawn
Last Changed: Jun 05, 2020
First Received: Feb 27, 2018
Disease(s): Aphasia, Primary Progressive, Repetitive Transcranical Magnetic Stimulation
Intervention(s): Magstim rTMS
rTMS as a Treatment for PPA
Status: Active, not recruiting
Last Changed: Jan 18, 2020
First Received: Jan 23, 2018
Disease(s): Logopenic Variant Primary Progressive Aphasia, Non-Fluent Primary Progressive Aphasia
Intervention(s): Active rTMS, SHAM rTMS
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Intranasal Oxytocin for Frontotemporal Dementia
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: Aug 24, 2017
Disease(s): Frontotemporal Dementia
Intervention(s): Syntocinon
Locations: UCLA, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Columbia University Medical Center, New York, New York, United States
University of Washington, Seattle, Washington, United States
... and 7 other locations.
Safety Study of Intranasal Oxytocin in Frontotemporal Dementia
Status: Completed
Last Changed: Nov 04, 2013
First Received: Jul 01, 2011
Disease(s): Frontotemporal Dementia
Intervention(s): oxytocin, Saline Nasal Mist
Locations: Cognitive Neurology and Alzheimer Research Centre, London, Ontario, Canada
Phase 1/2 Clinical Trial of PR006 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
Status: Recruiting
Last Changed: Sep 03, 2020
First Received: May 29, 2020
Disease(s): Frontotemporal Dementia
Intervention(s): PR006, Methylprednisolone, Sirolimus, Prednisone
Locations: UCSF Memory and Aging Center, 350 Parnassus Ave, Suite 706, San Francisco, California, United States
Mayo Clinic, 4500 San Pablo Road,, Jacksonville, Florida, United States
Bioclinica Orlando, 100 West Gore Street, Suite 202, Orlando, Florida, United States
University of Pennsylvania, The Penn FTD Center, 3 West Gates, Philadelphia, Pennsylvania, United States
Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
Status: Completed
Last Changed: Aug 08, 2018
First Received: Sep 09, 2013
Disease(s): Frontotemporal Dementia
Intervention(s): Intranasal oxytocin, Saline Nasal Mist
Locations: Parkwood Hospital, London, Ontario, Canada